Navigating the Rapid Evolution of Biologics: Critical Market Trends and the Imperative for Manufacturing Flexibility
  The biologics market is currently defined by several critical market trends that are fundamentally reshaping manufacturing paradigms and competitive strategy. Perhaps the most impactful is the rapid technological shift toward advanced modalities, including cell and gene therapies (CGT), which demand a complete re-tooling of traditional biomanufacturing facilities. Unlike monoclonal...
0 Commentarios 0 Acciones 90 Views 0 Vista previa
Patrocinados